Abstract:Impact of Acne Therapies on the Skin Microbiome: This graphical abstract illustrates how various acne treatments affect the cutaneous microbiome, particularly focusing on Cutibacterium acnes and overall microbial diversity. Common treatments like doxycycline and benzoyl peroxide generally decrease C. acnes and reduce alpha diversity, while isotretinoin has variable effects. Newer therapies, including probiotics and plant extracts, are highlighted for their potential to restore microbial balance, suggesting a shift towards microbiome‐focused treatment strategiesAcne vulgaris is a pervasive skin disease characterized by inflammation of sebaceous units surrounding hair follicles. It results from the complex interplay between skin physiology and the intricate cutaneous microbiome. Current acne treatments, while effective, have major limitations, prompting a shift towards microbiome‐based therapeutic approaches. This study aims to determine the relationship between acne and the cutaneous microbiome, assess the effects of current treatments on the cutaneous microbiome and explore the implications for developing new therapies. A systematic review was performed using PubMed and SCOPUS databases within the last 10 years. Methodological quality was assessed independently by two authors. The search retrieved 1830 records, of which 26 articles met the inclusion criteria. Meta‐analysis of alpha diversity change was assessed using fixed and randomized effect models per therapeutic group. Eight studies pertain to the role of the cutaneous microbiome in acne, identifying C. acnes, S. aureus and S. epidermidis as key contributors through overproliferation, commensalism or dysbiosis. Eleven studies discuss current acne treatments, including doxycycline (1), topical benzoyl peroxide (BPO) (4), isotretinoin (2), sulfacetamide‐sulfur (SSA) (2) and aminolevulinic acid‐photodynamic therapy (ALA‐PDT) (2), identified as modulating the cutaneous microbiome as a mechanism of efficacy in acne treatment. Seven studies discuss new treatments with topical probiotics, plant derivatives and protein derivatives, which contribute to acne clearance via modulation of dysbiosis, inflammatory markers and diversity indexes. A meta‐analysis of the effects of existing therapeutics on the cutaneous microbiome identified benzoyl peroxide as the only treatment to facilitate significant change in diversity. Despite the heterogeneity of study types and microbiome classifications limiting the analysis, this review underscores the complexity of microbial involvement in acne pathogenesis. It delineates the effects of acne therapeutics on microbial diversity, abundance and composition, emphasizing the necessity for personalized approaches in acne management based on microbiome modulation.

Skin microbiome in acne vulgaris, skin aging, and rosacea: An evidence-based review

Role of the skin microbiota and intestinal microbiome in rosacea

Dermatological Health in the Light of Skin Microbiome Evolution

How Microbiomes Affect Skin Aging: The Updated Evidence and Current Perspectives

Challenges and Future Therapeutic Opportunities

Potential Role of the Microbiome in Acne: A Comprehensive Review

The Skin Microbiome in Patients with Acne Vulgaris

Interaction between the microbiota and the skin barrier in aging skin: a comprehensive review

Evolving approaches to profiling the microbiome in skin disease

Gut-Skin axis and healthy skin: a systematic review

Advances in the human skin microbiota and its roles in cutaneous diseases

Rosacea, microbiome and probiotics: the gut-skin axis

Skin microbiome and causal relationships in three dermatological diseases: Evidence from Mendelian randomization and Bayesian weighting

The Microbiome and Acne: Perspectives for Treatment

Acne and the cutaneous microbiome: A systematic review of mechanisms and implications for treatments

Skin microbiome and skin disease: the example of rosacea

Gut–Skin Axis: Gut Microbiota as a Link Between Rosacea and Gastrointestinal Comorbidities

New Insights into the Skin Microbial Communities and Skin Aging

14339 the Skin Microbiome in Patients with Rosacea and Healthy Control Subjects

The Skin Microbiome: A New Actor in Inflammatory Acne

The role of macrophages in rosacea: implications for targeted therapies